Skip to main content
Clinical Trials/IRCT20220625055267N1
IRCT20220625055267N1
Not yet recruiting
Phase 3

Preparation, characterization and clinical evaluation of the effectiveness of a cotton-based topical product in stopping bleeding from the leech therapy wound

Mashhad University of Medical Sciences0 sites20 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Bleeding from the site of leech therapy.
Sponsor
Mashhad University of Medical Sciences
Enrollment
20
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adults who have leech therapy indication according to the doctor's opinion.

Exclusion Criteria

  • Clinical or laboratory evidence of coagulation disorder (ecchymosis, hematoma, petechiae purpura or disorder in PT, PTT, hemoglobin, platelets, glucose, calcium, urea, creatinine)
  • Patients who take drugs that affect coagulability, including anti\-platelets (aspirin, clopidogrel (Plavix), dipyridamole (Perzantin), ticlopidine (Ticlid), anticoagulants (warfarin, enoxaparin, rivaroxaban, heparin, streptokinase, etc.), blood thinners such as tranexamic acid, vitamin K, aminocaproic acid and statins and oral contraceptives and herbal anticoagulants such as products containing ginger and garlic
  • ??????? ????? ???????? ??????? ????? ??? ITP? ??????? ? ????? ????? ??????? ???? ????
  • Patients with various malignancies
  • Menstruating women
  • Leech therapy in the face area
  • Skin sensitivity to the product

Outcomes

Primary Outcomes

Not specified

Similar Trials